Frontlight ResearchEarly access
Obstructive sleep apnoea trials in Poland
5 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
- Where
- Bialystok, Poznan, Warsaw
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522699-94-00 - Phase 3Taking peopleAMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Cracow, Gdansk, Poznan, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571109 · EU 2024-520443-16-00 - Phase 3Taking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea on Positive Airway Pressure Therapy (MARITIME-OSA-1)
- Where
- Bialystok, Poznan, Warsaw
- Age
- 18 years and over
- People
- 115 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522703-14-00 - Phase 3Taking peopleAMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Cracow, Gdansk, Poznan, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571005 · EU 2024-520442-36-00 - No phaseTaking peopleIdentification of Biomarkers of Obstructive Sleep Apnea.
- Where
- Bialystok
- Age
- 18 years to 65 years
- People
- 120
- Run by
- Medical University of Bialystok
See details and how to joinNCT07723144